EQT Partners to Acquire Certara for $850 Million
Simpson Thacher is representing EQT Partners in connection with its announced acquisition of Certara, the leading provider of technology driven decision support solutions for drug development, from Arsenal Capital Partners for $850 million. This is EQT’s second major U.S. healthcare acquisition – the first being the Press Ganey acquisition in August 2016, in which Simpson Thacher also advised EQT.